Summary statistics from meta GWAS of DHEAS for - all samples (adjusted for age, log(BMI) and sex) - men only (adjusted for age and log(BMI)) - women only (adjusted for age and log(BMI)) These d
Aim: This first-in-human study evaluated safety and efficacy of CD40 agonist MEDI5083 with durvalumab in patients with advanced solid tumors. Methods: Patients received MEDI5083 (3–7.5 m
